2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$254.09+$0.69 (+0.27%)
Price as of Nov 12, 2026 8:48 AM EST- $37.5BMarket Cap
- 56.92%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$254.09+$0.69 (+0.27%)
BIIB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $253.40 | ||
Change | +$0.15 (+0.06%) | ||
Open | $249.78 | ||
High | $255.19 | ||
Low | $249.44 | ||
Previous Close | $253.25 | ||
Volume | 1,115,452 | ||
30-Day Average Volume | 1,315,414 | ||
1-Week Change | -0.42% | ||
1-Month Change | 12.27% | ||
1-Year Change | 56.92% | ||
3-Year Change | 12.73% | ||
5-Year Change | -4.94% | ||
Fundamentals | |||
Shares Outstanding | 147.8M | ||
Total Assets | $32.1B | ||
Market Cap | $37.5B | ||
Enterprise Value | $43.8B | ||
Period: QTR TTM FY | |||
Revenue | $2.1B | ||
Net Income | -$20.6M | ||
Free Cash Flow | $600.4M | ||
EBIT | $78.5M | ||
EBITDA | $319.6M | ||
Net Working Capital | $3.7B | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | 137 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 2 | ||
P/E | -1,810 | ||
PEG | 15 | ||
Price/Free Cash Flow | 62 | ||
Price/Operating Cash Flow | 58 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue